Imagine wearing a lightweight sleeve that acts like a shock absorber for your arm. It lets you move your hand normally to eat or drink, but it instantly cancels out the shaky movements caused by neurological issues. It's a purely mechanical solution, so there are no drugs or invasive brain surgeries involved.
Over 30 million people suffer from tremors that make eating and drinking nearly impossible. Current drug treatments only work for half the people and often cause heavy side effects, while surgery is too invasive for most.
A mechanical joint-damping orthosis (Stabilis) that suppresses involuntary tremors while allowing the user to move their arm voluntarily.
If you are an O&P provider dealing with a lack of non-invasive tremor solutions — this project developed a mechanical joint damping orthosis that reduces action tremors for multiple disorders. It offers a lightweight, ergonomic alternative to medication.
If you are a clinic dealing with patients who find pharmacological treatments insufficient — this project developed the Stabilis device that suppresses tremors while allowing voluntary movement. This helps patients return to activities of daily living without drug side effects.
If you are an insurer dealing with the high cost of invasive surgical interventions for tremors — this project developed a mechanical orthosis aimed to be covered by health insurance. It provides a cost-effective treatment option for a population of over 30 million people.
Based on available project data, the specific unit price is not mentioned, but the goal is for the device to be covered by health insurance.
The project indicates the device is aimed at serving the entire patient population, suggesting a plan for scale, though it currently requires more clinical validation for market-readiness.
Based on available project data, specific patent or licensing details are not provided, but the technology is developed by STIL BV.
The device still needs further clinical validation to obtain a CE-mark before it can be fully market-ready.
The project period ends on 2025-11-30, with the final results indicating that the device is currently moving toward a market-ready shape.
The project is led by a single SME, STIL BV from the Netherlands. With a 100% industry ratio and no university or research partners, the project is heavily focused on commercial application and product development rather than basic research.
Contact STIL BV in the Netherlands
Contact us to explore licensing or partnership opportunities for anti-tremor orthotics.
